-
Comparative analysis of the therapeutic effects of extracorporeal shock wave therapy and high-intensity laser therapy in lateral epicondylitis: a randomised clinical trial Rheumatol. Int. (IF 4.0) Pub Date : 2024-04-01
Abstract Lateral epicondylitis (LE) presents a substantial obstacle due to the pain and functional decline, frequently requiring non-surgical treatments. This study contrasts the efficacy of high-ıntensity laser therapy (HILT) and extracorporeal shock wave therapy (ESWT) in managing LE. A prospective, randomized comparative trial was conducted with 50 participants assigned to either HILT or ESWT groups
-
COVID-19 vaccination and infection status: a cross-sectional survey of patients with rheumatic diseases in China Rheumatol. Int. (IF 4.0) Pub Date : 2024-04-01 Chen Chen, Saisai Huang, Linyu Geng, Peng Lai, Huan Dou, Huayong Zhang, Haifeng Chen, Jun Liang, Lingyun Sun
-
The relationship between pain and depression and anxiety in patients with inflammatory arthritis: a systematic review protocol Rheumatol. Int. (IF 4.0) Pub Date : 2024-03-01 Natasha Cox, Ashley Hawarden, Ram Bajpai, Saeed Farooq, Helen Twohig, Sara Muller, Ian C. Scott
-
Progression of subclinical atherosclerosis in ankylosing spondylitis: a 10-year prospective study Rheumatol. Int. (IF 4.0) Pub Date : 2024-02-13 Aikaterini Arida, George E. Fragoulis, Dimitrios Terentes-Printzios, George Konstantonis, Athanasios D. Protogerou, Charalambos Vlachopoulos, Maria Tektonidou, Petros P. Sfikakis
-
Validity and reliability of measurement of peripheral oxygen saturation during the 6-Minute Walk Test in patients with systemic sclerosis Rheumatol. Int. (IF 4.0) Pub Date : 2024-02-10 Amanda Lynggaard Elkjær, Esben Uggerby Næser, Katja Thorup Aaen, Henrik Lynge Hovgaard, Peter Juhl-Olsen, Elisabeth Bendstrup, Klaus Søndergaard
-
Telerehabilitation: lessons from the COVID-19 pandemic and future perspectives Rheumatol. Int. (IF 4.0) Pub Date : 2024-02-06 Burhan Fatih Kocyigit, Meirgul I. Assylbek, Marlen Yessirkepov
-
Systemic sclerosis associated respiratory involvement: Scopus-based analysis of articles in 2013–2022 Rheumatol. Int. (IF 4.0) Pub Date : 2024-02-06 Bohdana Doskaliuk, Iryna Kreminska, Yulia Fedorchenko, Liubomyr Zaiats, Roman Yatsyshyn
-
Clinical and anamnestic features of patients with systemic vasculitis: a single-center retrospective study Rheumatol. Int. (IF 4.0) Pub Date : 2024-02-06 Akerke Auanassova, Marlen Yessirkepov
Systemic vasculitides are the most complex and problematic autoimmune rheumatic diseases characterized by affections of large, medium, or small vessels. Although the immunopathogenesis of vasculitides is thoroughly studied, the epidemiology and etiology are poorly explored. The main triggers of vasculitides are environmental, genetic, and various infectious factors. Diagnosis of vasculitides is complicated
-
Cross-sectional analysis of cardiovascular disease and risk factors in patients with spondyloarthritis: a real-life evidence from biostar nationwide registry Rheumatol. Int. (IF 4.0) Pub Date : 2024-02-06 Mehmet Tuncay Duruöz, Hatice Bodur, Şebnem Ataman, Gülcan Gürer, Özgür Akgül, Hasan Fatih Çay, Erhan Çapkın, İlhan Sezer, Aylin Rezvani, Meltem Alkan Melikoğlu, İlker Yağcı, Fatma Gül Yurdakul, Feride Nur Göğüş, Ayhan Kamanlı, Remzi Çevik, Lale Altan
The association between spondyloarthritis and cardiovascular (CV) diseases is complex with variable outcomes. This study aimed to assess the prevalence rates of CV diseases and to analyze the impact of CV risk factors on CV disease in patients with spondyloarthritis. A multi-center cross-sectional study using the BioSTAR (Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs Registry)
-
Exploring 5-year changes in general and skin health-related quality of life in psoriatic arthritis patients Rheumatol. Int. (IF 4.0) Pub Date : 2024-02-06
Abstract Psoriatic arthritis (PsA) carries a severe disease burden, often leading to deterioration of health-related quality of life (HRQoL). Different comorbidities that are relatively prevalent in PsA are also responsible for compromised HRQoL. To assess real-world data of a 5-year follow-up cohort of PsA patients, focusing on changes in general HRQoL, skin HRQoL, and comorbidities. In this prospective
-
Glucocorticoid discontinuation rate and risk factors for relapses in a contemporary cohort of patients with giant cell arteritis Rheumatol. Int. (IF 4.0) Pub Date : 2024-02-01 Christina Tsalapaki, Argyro Lazarini, Evaggelia Argyriou, Vassiliki Dania, Kyriaki Boki, Gerasimos Evangelatos, Alexios Iliopoulos, Maria Pappa, Petros P. Sfikakis, Maria G. Tektonidou, Athanasios Georgountzos, Euripidis Kaltsonoudis, Paraskevi Voulgari, Alexandros A. Drosos, Evaggelos Theotikos, Charalampos Papagoras, Theodoros Dimitroulas, Alexandros Garyfallos, Evaggelia Kataxaki, Georgios Vosvotekas
-
A new perspective on vitamin B12 deficiency in rheumatology: a case-based review Rheumatol. Int. (IF 4.0) Pub Date : 2024-01-31 Natalia Aleksandra Dułak, Magdalena Rytlewska, Marta Jaskólska, Michał Chmielewski
Vitamin B12 (cobalamin) deficiency is common in patients with rheumatic diseases. Pernicious anemia is a well-known cause, but recent reports suggest that autoimmune-derived deficiency may not be limited to this cause alone. Symptoms of low vitamin B12 concentration are often deceptive, mimicking and overlapping with symptoms of other conditions. Neuropsychiatric manifestations, anemia, and fatigue
-
Rehabilitation of patients with inflammatory rheumatic diseases and comorbidities: unmet needs Rheumatol. Int. (IF 4.0) Pub Date : 2024-01-31 Yuliya Fedorchenko, Khaiyom Mahmudov, Zhumabek Abenov, Olena Zimba, Marlen Yessirkepov
Comorbidities may contribute to inadequate response to therapy and accelerate disability in various rheumatic diseases such as rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and psoriatic arthritis (PsA). Cardiovascular, oncological, and infectious comorbidities are common in rheumatic patients. The rehabilitation of patients with inflammatory rheumatic diseases (IRDs) with comorbidities
-
Drug persistence in patients with rheumatic and musculoskeletal diseases during a major economic crisis: results from a nationwide cross-sectional online survey Rheumatol. Int. (IF 4.0) Pub Date : 2024-01-31 Serena Asmar, Jamil Messaykeh, Nadeen Hilal, Mohamad Ali Rida, Kamel Mroue, Krystel Aouad, Fouad Minkara, Arlette Hajjar, Nelly Ziade
-
Pre-assessment of patients with suspected axial spondyloarthritis combining student-led clinics and telemedicine: a qualitative study Rheumatol. Int. (IF 4.0) Pub Date : 2024-01-30 Katharina Boy, Sophie von Rohr, Susann May, Sebastian Kuhn, Georg Schett, Hannah Labinsky, Johannes Knitza, Felix Muehlensiepen
-
The crosstalk between subjective fibromyalgia, mental health symptoms and the use of over-the-counter analgesics in female Syrian refugees: a cross-sectional web-based study Rheumatol. Int. (IF 4.0) Pub Date : 2024-01-29 Omar Gammoh, Alaa A. A. Aljabali, Murtaza M. Tambuwala
Suboptimal fibromyalgia management with over-the-counter analgesics leads to deteriorated outcomes for pain and mental health symptoms especially in low-income countries hosting refugees. To examine the association between the over-the-counter analgesics and the severity of fibromyalgia, depression, anxiety and PTSD symptoms in a cohort of Syrian refugees. This is a cross-sectional study. Fibromyalgia
-
Post-stroke rehabilitation in the peri-pandemic COVID-19 era Rheumatol. Int. (IF 4.0) Pub Date : 2024-01-23 Meirgul I. Assylbek, Burhan Fatih Kocyigit, Marlen Yessirkepov, Olena Zimba
-
Use of prescribed analgesics before and after exercise therapy and patient education in patients with knee or hip osteoarthritis Rheumatol. Int. (IF 4.0) Pub Date : 2024-02-01
Abstract The aim of this study was to investigate utilisation patterns of prescribed analgesics before, during, and after an exercise therapy and patient education program among patients with knee or hip osteoarthritis. This cohort study is based on data from the nationwide Good Life with osteoarthritis in Denmark (GLA:D®) patient-register linked with national health registries including data on prescribed
-
Three out of four working-age patients have fulfilled expectations towards paid employment six months after total hip or knee arthroplasty: a multicentre cohort study Rheumatol. Int. (IF 4.0) Pub Date : 2024-02-01 Tamara Kamp, Martin Stevens, Thea P. M. Vliet Vlieland, Rob G. H. H. Nelissen, Sandra Brouwer, Maaike G. J. Gademan
-
The effects of hydroxychloroquine and its promising use in refractory obstetric antiphospholipid syndrome Rheumatol. Int. (IF 4.0) Pub Date : 2024-02-01 Juan J. Fierro, Manuela Velásquez-Berrío, Alexandra Ospina, Svenja Henning, Karina de Leeuw, Ángela P. Cadavid J
-
Clinical presentation and genetic variants in patients with autoinflammatory diseases: results from the German GARROD registry Rheumatol. Int. (IF 4.0) Pub Date : 2024-02-01 Norbert Blank, Ina Kötter, Marc Schmalzing, Jürgen Rech, Karoline Krause, Birgit Köhler, Dorothee Kaudewitz, Martin Nitschke, Christian S. Haas, Hanns-Martin Lorenz, Martin Krusche
Abstract To investigate clinical symptoms and genetic variants in patients from the German anti-IL-1 registry for autoinflammatory orphan diseases (GARROD) between 2013 and 2022. Multicentre, retrospective analysis of demographic, clinical and genetic data of patients with autoinflammatory diseases (AID) who received anti-IL-1 targeted therapy. The cohort comprised 152 patients with familial Mediterranean
-
Predicting comorbid mental health difficulties in people with autoimmune arthritis Rheumatol. Int. (IF 4.0) Pub Date : 2024-01-18 Caitlin A Hibbs
Little is known about variables impacting the association between mental health difficulties and autoimmune conditions. This study investigates whether, age of onset, adverse childhood experiences (ACEs), and ‘illness invisibility’ predict comorbid mental health difficulties in people with autoimmune arthritis. Participants with autoimmune arthritis (N = 209) were recruited via social media platforms
-
Prediction of the acceptance of telemedicine among rheumatic patients: a machine learning-powered secondary analysis of German survey data Rheumatol. Int. (IF 4.0) Pub Date : 2024-01-11 Felix Muehlensiepen, Pascal Petit, Johannes Knitza, Martin Welcker, Nicolas Vuillerme
-
Validity and reliability of the Duruöz Hand Index in patients with psoriatic arthritis Rheumatol. Int. (IF 4.0) Pub Date : 2024-01-09 Mehmet Tuncay Duruöz, Kemal Nas, Sevtap Acer Kasman, Nuran Öz, Emre Uzun, Halise Hande Gezer
Objective The Duruöz Hand Index (DHI) is a valuable scale developed for evaluating hand functions of patients with rheumatoid arthritis and subsequently proven to be valid and reliable in various diseases. This study aims to investigate the validity and reliability of the DHI in patients with psoriatic arthritis (PsA). Methods Patients diagnosed with PsA according to CASPAR criteria were enrolled.
-
Potential role of camel, mare milk, and their products in inflammatory rheumatic diseases Rheumatol. Int. (IF 4.0) Pub Date : 2024-01-06 Emine Kocyigit, Ruslan Abdurakhmanov, Burhan Fatih Kocyigit
-
Trends in health care of patients with vasculitides, including giant cell arteritis, Takayasu arteritis, ANCA-associated vasculitis and Behçet’s disease: cross-sectional data of the German National Database 2007–2021 Rheumatol. Int. (IF 4.0) Pub Date : 2024-01-05
Abstract The aim of this study is to present the current care situation of patients with giant cell arteritis (GCA), Takayasu arteritis (TAK), ANCA-associated vasculitis (AAV) and Behçet’s disease (BD). Trends over the last 15 years will reflect improvements and remaining deficits in the management of vasculitides. Consecutive cross-sectional data from patients with vasculitides from the German National
-
Integrative non-pharmacological care for individuals at risk of rheumatoid arthritis Rheumatol. Int. (IF 4.0) Pub Date : 2024-01-05 Javier Courel-Ibáñez, Tomas Vetrovsky, Nora Růžičková, Concepción Marañón, Krzysztof Durkalec-Michalski, Michal Tomcik, Mária Filková
-
SARS-CoV-2 seroprevalence in patients with autoimmune rheumatic diseases versus family controls: a multi-city cross-sectional survey Rheumatol. Int. (IF 4.0) Pub Date : 2024-01-01 Ramnath Misra, Debdutta Bhattacharya, Sakir Ahmed, Sanjiv Amin, Vineeta Shobha, Alakendu Ghosh, Sapan C. Pandya, Debaprasad Parai, Prasanta Padhan, Subhadra Priyadarshini, Ipsa Mohapatra, A. Raj Kumar Patro, Ambika Prasad Mohanty, Sanghamitra Pati
-
Physical activity guidance in the rheumatology clinic—what matters for patients with rheumatoid arthritis? A qualitative study Rheumatol. Int. (IF 4.0) Pub Date : 2024-01-01 Tanja Thomsen, Mette Aadahl, Merete Lund Hetland, Bente Appel Esbensen
Abstract Higher proportions of patients with rheumatoid arthritis (RA) are physically inactive compared to the general population. A barrier to engaging in physical activity (PA) may be lack of consistent PA guidance from health professionals (HPRs). This qualitative study aimed to explore daily PA levels and the patients’ perspectives on current and future PA guidance from HPRs. We recruited 20 participants
-
Correlates of breakthrough COVID-19 in vaccinated patients with systemic sclerosis: survival analysis from a multicentre international patient-reported survey Rheumatol. Int. (IF 4.0) Pub Date : 2024-01-01 Sakir Ahmed, Latika Gupta, Masataka Kuwana, John D. Pauling, Jessica Day, Naveen Ravichandran, Mrudula Joshi, Ioannis Parodis, Parikshit Sen, Kshitij Jagtap, Elena Nikiphorou, Sreoshy Saha, Vishwesh Agarwal, Tulika Chatterjee, James B. Lilleker, Sinan Kardes, Marcin Milchert, Tamer Gheita, Babur Salim, Tsvetelina Velikova, Abraham Edgar Gracia-Ramos, Ai Lyn Tan, Arvind Nune, Lorenzo Cavagna, Miguel
-
Celiac trunk thrombosis in a patient with antiphospholipid syndrome induced by median arcuate ligament compression: a case presentation and literature review Rheumatol. Int. (IF 4.0) Pub Date : 2024-01-01 Paulina Janiak, Żaneta Smoleńska, Monika Skotarczak, Zbigniew Zdrojewski
-
An overlapping case of IgG4-related disease and systemic lupus erythematosus treated with belimumab: a case-based review Rheumatol. Int. (IF 4.0) Pub Date : 2024-01-03
Abstract IgG4-related disease (IgG4-RD) is a systemic condition in which IgG4+ plasma cell infiltration and fibrosis cause organ swelling and lead to diverse clinical manifestations. Although IgG4-RD typically responds to glucocorticoids (GCs), relapse during tapering occurs and an early GC-sparing approach might therefore be beneficial. Systemic lupus erythematosus (SLE) is a chronic inflammatory
-
Prevalence of cardiovascular diseases and traditional cardiovascular risk factors in patients with rheumatoid arthritis: a real-life evidence from BioSTAR nationwide registry Rheumatol. Int. (IF 4.0) Pub Date : 2023-12-29 Mehmet Tuncay Duruöz, Şebnem Ataman, Hatice Bodur, Hasan Fatih Çay, Meltem Alkan Melikoğlu, Özgür Akgül, Erhan Çapkın, Gülcan Gürer, Remzi Çevik, Feride Nur Göğüş, Ayhan Kamanlı, Fatma Gül Yurdakul, İlker Yağcı, Aylin Rezvani, Lale Altan
Patients with rheumatoid arthritis (RA) have increased morbidity and mortality due to cardiovascular (CV) comorbidities. The association of CV diseases (CVD) and traditional CV risk factors has been debated, depending on patient and RA characteristics. This study aimed to find the prevalence of CVD and CV risk factors in patients with RA. A multi-center cross-sectional study was performed on RA patients
-
Comparison of reporting rates of arthritis and arthralgia following AstraZeneca, Pfizer-BioNTech, Moderna, and Janssen vaccine administration against SARS-CoV-2 in 2021: analysis of European pharmacovigilance large-scale data Rheumatol. Int. (IF 4.0) Pub Date : 2023-12-24 Elena Primorac Padjen, Robert Marcec, Matija Zidar, Ivan Padjen, Tomislav Katanec, Branimir Anic, Robert Likic
-
Pseudoxanthoma elasticum veiled as vasculitis: shedding light on an uncommon disorder and an in-depth review of the literature Rheumatol. Int. (IF 4.0) Pub Date : 2023-12-23 Rand Murshidi, Fatima Alnaimat, Salameh Al-Halaseh, Suzan Hanandeh, Salsabiela Bani Hamad, Maram Abdaljaleel, Nosaiba Al Ryalat
-
Age-related variations in trunk composition and patterns of regional bone and soft tissue changes in adult Caucasian women by DXA Rheumatol. Int. (IF 4.0) Pub Date : 2023-12-23 Stavroula J. Theodorou, Daphne J. Theodorou, Vassiliki Kigka, Ioannis Gkiatas, Andreas Fotopoulos
We explored the regional variations in body composition with advancing age in healthy Caucasian females living in the Mediterranean area. The objectives of this study were to establish body composition values for the trunk in healthy women of a Greek origin and to evaluate the effects of aging on the distribution of truncal bone mass, fat mass (FM) and lean mass (LM). Body composition of the trunk
-
Clinical characteristics, disease trajectories and management of vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome: a systematic review Rheumatol. Int. (IF 4.0) Pub Date : 2023-12-21 Koushan Kouranloo, Mrinalini Dey, Jude Almutawa, Nikki Myall, Arvind Nune
-
Psychological interventions to improve pain, fatigue, anxiety, depression, and quality of life in children and adults with hypermobility spectrum disorders and Ehlers-Danlos syndrome: a systematic review Rheumatol. Int. (IF 4.0) Pub Date : 2023-12-13 Natalie L. Clark, Gurvinder Singh Kainth, Melissa Johnson, Amar Rangan, Lucksy Kottam, Katherine Swainston
-
Pattern of disease expression in SLE patients with antiphospholipid antibodies: data from Indian Systemic Lupus Erythematosus Inception cohort (INSPIRE) Rheumatol. Int. (IF 4.0) Pub Date : 2023-12-12 Vineeta Shobha, Liza Rajasekhar, Sandra Manuel, V. Nayana, Chengappa Kavadichanda, Deepika Kounassegarane, Ashish J. Mathew, Ranjan Gupta, Manish Rathi, Parasar Ghosh, Saumya Ranjan Tripathy, Bidyut Das, Sumithra Selvam, Abhishek Kumar Singh, Ankita Singh, Avinash Jain, Amita Aggarwal
-
Survival differences in rheumatoid arthritis interstitial lung disease and idiopathic pulmonary fibrosis may be explained by delays in presentation: results from multivariate analysis in a monocentric UK study Rheumatol. Int. (IF 4.0) Pub Date : 2023-12-12 Shirish Dubey, Felix Woodhead
-
COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group Rheumatol. Int. (IF 4.0) Pub Date : 2023-12-07 Suhrud Panchawagh, Naveen Ravichandran, Bhupen Barman, Arvind Nune, Mahnoor Javaid, Abraham Edgar Gracia-Ramos, Jessica Day, Mrudula Joshi, Masataka Kuwana, Sreoshy Saha, Arunkumar R. Pande, Carlo Vinicio Caballero-Uribe, Tsvetelina Velikova, Ioannis Parodis, Johannes Knitza, Esha Kadam, Ai Lyn Tan, Samuel Katsuyuki Shinjo, Hiya Boro, Rohit Aggarwal, Vikas Agarwal, Tulika Chatterjee, Latika Gupta
To investigate the frequency, profile, and severity of COVID-19 breakthrough infections (BI) in patients with type I diabetes mellitus (T1DM) compared to healthy controls (HC) after vaccination. The second COVID-19 Vaccination in Autoimmune Diseases (COVAD-2) survey is a multinational cross-sectional electronic survey which has collected data on patients suffering from various autoimmune diseases including
-
Serum IL-17 and TNFα as prognostic biomarkers in systemic sclerosis patients: a prospective study Rheumatol. Int. (IF 4.0) Pub Date : 2023-12-05 Joanna Kosałka-Węgiel, Sabina Lichołai, Renata Pacholczak-Madej, Sylwia Dziedzina, Mamert Milewski, Piotr Kuszmiersz, Anna Korona, Jolanta Gąsior, Aleksandra Matyja-Bednarczyk, Helena Kwiatkowska, Lech Zaręba, Andżelika Siwiec-Koźlik, Paweł Koźlik-Siwiec, Anita Wach, Weronika Pociej-Marciak, Marek Sanak, Jacek Musiał, Stanisława Bazan-Socha, Mariusz Korkosz
Recent reports have demonstrated that endothelial injury is critical in the pathogenesis of systemic sclerosis (SSc) and is associated with increased levels of circulating inflammatory biomarkers. This study aims to analyze the serum concentrations of selected cytokines and evaluate their relationship with SSc clinics and the long-term course of the disease. This study included 43 SSc patients and
-
Quality of reporting and nature of harms in clinical trials on supervised exercise in patients with rheumatoid arthritis or axial spondyloarthritis Rheumatol. Int. (IF 4.0) Pub Date : 2023-11-30 Max M. H. Teuwen, Thea P. M. Vliet Vlieland, Salima F. E. van Weely, Jan W. Schoones, Anne-Kathrin Rausch Osthoff, Carsten B. Juhl, Karin Niedermann, Maaike G. J. Gademan, Cornelia H. M. van den Ende
-
Functional limitations of people with rheumatoid arthritis or axial spondyloarthritis and severe functional disability: a cross-sectional descriptive study Rheumatol. Int. (IF 4.0) Pub Date : 2023-11-25 Max M. H. Teuwen, Salima F. E. van Weely, Thea P. M. Vliet Vlieland, Thom Douw, Dirkjan van Schaardenburg, Alfons A. den Broeder, Astrid M. van Tubergen, Maria A. T. van Wissen, Cornelia H. M. van den Ende, Maaike G. J. Gademan
-
Healing refractory livedoid vasculopathy-related skin ulcers by ozone therapy: a case-based review Rheumatol. Int. (IF 4.0) Pub Date : 2023-11-24 Gulsah Yasa Ozturk, Burhan Fatih Kocyigit
-
Musculoskeletal disorders and pain in agricultural workers in Low- and Middle-Income Countries: a systematic review and meta-analysis Rheumatol. Int. (IF 4.0) Pub Date : 2023-11-24 Mrithula Shivakumar, Victoria Welsh, Ram Bajpai, Toby Helliwell, Christian Mallen, Michelle Robinson, Thomas Shepherd
-
Kidney histopathology in predicting flares following drug withdrawal in proliferative lupus nephritis in clinical remission Rheumatol. Int. (IF 4.0) Pub Date : 2023-11-21 Aishwarya Gopal, Chengappa Kavadichanda, Mohan Sreelekha Gayathri, Mamatha Gorijavolu, Devender Bairwa, Christina Mary Mariaselvam, Bheemanathi Hanuman Srinivas, Molly Mary Thabah, Vir Singh Negi
-
JAK inhibitors improve ATP production and mitochondrial function in rheumatoid arthritis: a pilot study Rheumatol. Int. (IF 4.0) Pub Date : 2023-11-20 Valentina Mihaylova, Maria Kazakova, Zguro Batalov, Rositsa Karalilova, Anastas Batalov, Victoria Sarafian
-
Peripheral and ocular microvascular alterations in systemic sclerosis: observations from capillaroscopic assessments, perfusion peripheral analysis, and optical coherence tomography angiography Rheumatol. Int. (IF 4.0) Pub Date : 2023-11-17 Carlo Alberto Cutolo, Andrea Cere, Paola Toma, Tommaso Cannavacciuolo, Chiara Toma, Serena Balito, Veronica Gerli, Vanessa Smith, Alberto Sulli, Sabrina Paolino, Emanuele Gotelli, Carlo Enrico Traverso, Massimo Nicolò, Maurizio Cutolo, Elvis Hysa
-
Scleromalacia perforans as an early manifestation of late-onset rheumatoid arthritis: a case-based review Rheumatol. Int. (IF 4.0) Pub Date : 2023-11-04 Letícia Queiroga de Figueiredo, Fernanda Oliveira de Andrade Lopes, André Silva Franco, Henrique Ayres Mayrink Giardini, Lissiane Karine Noronha Guedes, Karina Rossi Bonfiglioli, Andrea Yukie Shimabuco, Ana Cristina de Medeiros Ribeiro, Diogo Souza Domiciano
-
Hyperthyroidism is an important risk factor for incident gout particularly in younger age groups and males. Rheumatol. Int. (IF 4.0) Pub Date : 2023-11-02 Yunwen Tao,Changyan Xu,Chen Fang
-
Exercise therapy for improving cardiovascular health in rheumatoid arthritis Rheumatol. Int. (IF 4.0) Pub Date : 2023-10-31 Ilke Coskun Benlidayi
-
Franz Liszt’s hand osteoarthritis Rheumatol. Int. (IF 4.0) Pub Date : 2023-10-31 Ilke Coskun Benlidayi
-
SAPHO syndrome: current clinical, diagnostic and treatment approaches Rheumatol. Int. (IF 4.0) Pub Date : 2023-10-27 Tuba Demirci Yildirim, İsmail Sari
-
Advancing AI in rheumatology: critical reflections and proposals for future research using large language models. Rheumatol. Int. (IF 4.0) Pub Date : 2023-10-27 Partha Pratim Ray
-
Endorsement of reporting guidelines and clinical trial registration across Scopus-indexed rheumatology journals: a cross-sectional analysis Rheumatol. Int. (IF 4.0) Pub Date : 2023-10-20 Trevon Jelinek, Alexandra Shumard, Jay Modi, Caleb Smith, Danya Nees, Griffin Hughes, Matt Vassar
-
Pneumocystosis in a patient with rheumatoid arthritis on adalimumab therapy: a case-based review Rheumatol. Int. (IF 4.0) Pub Date : 2023-10-18 Dimitris C. Kounatidis, Vasileios Papadimitropoulos, Konstantinos Avramidis, Evgenia Plenga, Ioanna Tsiara, Elena Avgoustou, Natalia Vallianou, Dimitrios Vassilopoulos
-
Miliarial-type gout in association with chronic use of glucocorticoids Rheumatol. Int. (IF 4.0) Pub Date : 2023-10-18 A. Enríquez-Luna, C. Soto-Fajardo, F. Carranza-Enríquez, D. Clavijo-Cornejo, A. Lopez-Reyes, C. Pineda
-
Vitamin B12 (cobalamin) supplementation for the management of autoimmune rheumatic diseases: potential indications and opportunity for future research. Rheumatol. Int. (IF 4.0) Pub Date : 2023-10-17 Jozélio Freire de Carvalho,Steven John Coles,Allain Amador Bueno
-
Predictors of treatment failure of non-steroidal anti-inflammatory drugs in patients with axial spondyloarthritis with focus on haptoglobin, haptoglobin polymorphism and zonulin Rheumatol. Int. (IF 4.0) Pub Date : 2023-10-17 Magdalena Chmielińska, Marzena Olesińska, Anna Felis-Giemza, Agnieszka Paradowska-Gorycka, Karolina Palej, Julita Rejmer-Szcześniak, Dariusz Szukiewicz